Abstract
Objective:
To develop initial American College of Rheumatology (ACR) guidelines on the use of exercise, rehabilitation, diet, and additional integrative interventions in conjunction with disease-modifying anti-rheumatic drugs (DMARDs) as part of an integrative management approach for people with rheumatoid arthritis (RA).
Methods:
An interprofessional guideline development group constructed clinically relevant Population, Intervention, Comparator, and Outcome (PICO) questions. A literature review team then completed a systematic literature review and applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to rate the certainty of evidence. An interprofessional voting panel (n=20 participants) that included 3 persons with RA achieved consensus on the direction (for or against) and strength (strong or conditional) of recommendations.
Results:
The voting panel achieved consensus on 28 recommendations for the use of integrative interventions in conjunction with DMARDs for the management of RA. Consistent engagement in exercise received a strong recommendation. Of 27 conditional recommendations, 4 pertained to exercise, 13 to rehabilitation, 3 to diet, and 7 to additional integrative interventions. These recommendations are specific to RA management, recognizing that other medical indications and general health benefits may exist for many of these interventions.
Discussion:
This guideline provides initial ACR recommendations on integrative interventions for the management of RA to accompany DMARD treatments. The broad range of interventions included in these recommendations illustrates the importance of an interprofessional team-based approach to RA management. The conditional nature of most recommendations requires clinicians to engage patients in shared decision making when applying these recommendations.
Keywords: Rheumatoid Arthritis, Integrative Medicine, Physical Activity, Diet, Dietary Supplements, Rehabilitation, Physical Therapy, Occupational Therapy
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory condition, and improved outcomes occur with the early diagnosis, evaluation, and management. The American College of Rheumatology (ACR) has previously published pharmacologic guidelines to aid clinicians and people with RA (1–4). In addition to pharmacological interventions, people with RA and their clinicians consider how exercise, rehabilitation, diet, and additional adjunctive therapies can benefit and be integrated into their disease management. Using the Grading of Recommendations Assessment, Development and Evaluation [GRADE] methodology, the ACR developed this first guideline to support decision making when using specific integrative interventions in the management of RA. The interventions considered in this guideline are defined in Table 1. Although people with RA may have other indications for these interventions (e.g., comorbidities), this guideline focuses specifically on managing RA.
Table 1.
Intervention | Description and/or examples |
---|---|
Exercise | |
Physical activity | Movement of the body requiring energy expenditure. |
Exercise | Performance of physical activity in regular and structured manner to improve fitness and health. |
Aerobic exercise | Exercise intended to improve cardiorespiratory fitness and muscular endurance. Examples include walking, biking or cycling, running, hiking, aerobics, rowing, swimming, using an elliptical. |
Aquatic exercise | Exercise performed in water, containing elements of both aerobic and resistance exercise. Examples include swimming, water aerobics, water walking or jogging. |
Resistance exercise | Exercise intended to increase muscular strength. Examples include free weights, weight machines, resistance bands, Pilates. |
Mind-body exercise | Exercise that combines movement, mental focus, and controlled breathing. Examples include yoga, Tai Chi, Qigong. |
Rehabilitation | |
Comprehensive occupational therapy | Evaluation and treatment by Occupational Therapist with the goal of increasing physical function and participation. Receives patient-centered individualized treatment. Components of OT services vary and may include arthritis education, ADL evaluation and training, joint protection, activity pacing, work simplification and fatigue management, exercise (particularly for the hand and arm), splinting/orthotics, provision of assistive/adaptive devices, environmental adaptations, work and leisure counselling/rehabilitation, work-site assessment, sexual advice, relaxation, and pain and stress management training. |
Comprehensive physical therapy | Evaluation and treatment by a physical therapist. Components of PT services will vary and should include exercise. May also include functional training and physical activity, energy conservation, workplace accommodations, mobility and gait training, manual therapy, self-management education, electrotherapy, application of orthoses, instruction in assistive devices, pain-management including thermal therapy. |
Hand therapy exercises | Exercises of the hand to improve mobility and strength. |
Bracing and orthoses | Devices to correct and support musculoskeletal function, improve joint alignment, or protect the joint. Examples include wrist and finger splints, foot or knee orthoses, compression gloves, taping. |
Joint protection techniques | Self-management approach that aims to maintain function by providing people with ways to alter work methods and movement patterns of affected joints to reduce pain, inflammation, and joint stress. Examples include changing the way of performing activities to avoid pain, resting, using alternative muscle groups. |
Activity pacing | Balancing activity and rest to accomplish activities. Includes activity pacing, energy conservation, activity modification, fatigue management techniques. |
Assistive devices | Devices to assist with mobility. Examples include crutches, canes, walkers, wheelchairs, tricycles, scooters. |
Adaptive equipment | Devices to assist with activities of daily living. Examples include built up and/or long handled equipment, sock aide, button hook, reachers, pill cutters, cell phone holders. |
Environmental adaptations | Adapting environment to improve safety. Examples include adaptations for toileting (raised toilet seat, commode, toilet safety rail), showering (tub seat, handheld shower, walk in bath), grab bars, ramps, stair lifts, home modification. |
Vocational rehabilitation | Training programs to overcome barriers preventing successful employment. |
Work site evaluation and modifications | Evaluating and adjusting work-site conditions and duties for safety and well-being. |
Dietary | |
Formally defined diet | Specific formally defined diets evaluated in this guideline were: anti-inflammatory, Mediterranean-style, ketogenic, paleo, gluten-free, vegetarian, vegan, intermittent fasting, elemental, elimination, raw foods, whole food plant-based. |
Mediterranean-style diet | Diet pattern that emphasizes intake of vegetables, fruits, whole grains, nuts, seeds, and olive oil; moderate amounts of low-fat dairy and fish; and limits added sugars, sodium, highly processed foods, refined carbohydrates, and saturated fats. |
Dietary supplement | Substances used to add nutrients, botanicals, herbs, or microbials (probiotics) to the diet. Specific supplements evaluated in this guideline were vitamin D, probiotics, fish oil and omega fatty acids, antioxidants (selenium, zinc, vitamin A, vitamin C, vitamin E), turmeric, glucosamine, γ-linolenic acid, borage seed oil, evening primrose oil, black currant seed oil, selenium, Boswellia, ginger. |
Weight loss | Intentional loss of body weight. Examples include lifestyle modification through diet and/or exercise, support groups, health coaching, medically-supervised weight loss programs, branded dietary weight loss programs, weight loss surgery. |
Additional adjunctive therapies | |
Self-management program | Standardized program to guide self-management. Examples include Arthritis Self-Management Program, Chronic Disease Self-Management Program, Better Choices Better Health, Tomando Control de su Salud, RA Self-Management Intervention, OPERAS (an On-demand Program to EmpoweR Active Self-management). |
Cognitive behavioral therapy | Psychological therapy to identify and change thought and behavior patterns. |
Mind-body approaches | Practices engaging both mind and body functions. Examples include biofeedback, goal setting, meditation, mindfulness, breathing exercises, progressive muscle relaxation, guided imagery. |
Acupuncture | Stimulation of specific body points through insertion of thin needles. |
Massage therapy | Rubbing and kneading of muscles and joints with the hands. Examples include Swedish, Deep Tissue, Trigger Point. |
Thermal modalities | Use of heat and cold for medical treatment. Examples include cryotherapy, heat, therapeutic ultrasound, infrared sauna, paraffin therapy, and laser therapy. |
Electrotherapy | Use of electrical energy for medical treatment. Examples include transcutaneous electrical nerve stimulation (TENS), neuro-muscular electrical nerve stimulation (NMES). |
Vagal nerve stimulation | Implantation of a device to stimulate the vagus nerve with electrical impulses. |
Chiropractic | Diagnosis and manipulation of malaligned joints, particularly the spine. |
Tobacco cessation | Counseling on tobacco cessation, tobacco cessation programs (phone, mobile applications), nicotine replacement therapies, tobacco cessation medications without nicotine. |
Abbreviations: ADL, activities of daily living; OT, occupational therapy; PT, physical therapy
METHODS
This guideline follows the ACR guideline development process and ACR policy guiding management of conflicts of interest and disclosures (https://www.rheumatology.org/Practice-Quality/Clinical-Support/Clinical-Practice-Guidelines), which includes GRADE methodology (5, 6) and adheres to AGREE criteria (7). Supplementary Appendix 1 includes a detailed description of the methods. Briefly, the core leadership team (BE, BS, NB, JB, CO, GG) drafted clinical population, intervention, comparator, and outcome (PICO) questions (See Supplementary Appendix 2). For most questions, the critical outcomes were physical function, which refers to the ability to perform both basic and instrumental activities of daily living, and pain. Disease activity was an additional critical outcome for questions pertaining to diet and dietary supplements. Work outcomes were additional critical outcomes for questions pertaining to vocational rehabilitation and work site evaluation and modification. The Literature Review Team performed a systematic literature review for all PICO questions, extracted relevant study data, graded the quality of evidence (high, moderate, low, very low) and produced the evidence report (see Supplementary Appendix 3). A Patient Panel of 12 patients with varying manifestations of RA and varying experiences with the considered interventions for RA management met virtually. This panel was moderated by a member of the core team (JB) and literature review team (LT). The panel reviewed the evidence report (along with a summary and interpretation by the moderator) and provided patient perspectives and preferences for consideration by the Voting Panel. At a separate Voting Panel meeting held virtually, the resulting evidence was reviewed, patient perspectives considered, and recommendations formulated and voted on. Three members of the Patient Panel were also members of the Voting Panel, to ensure the Patient Panel’s perspective was considered when final decisions on the recommendations were made. Rosters of the Core Leadership Team, Literature Review Team, Voting Panel, and Patient Panel are included in Supplementary Appendix 4. These teams included individuals with expertise in epidemiology, exercise physiology, GRADE methodology, integrative medicine, nursing, nutrition, occupational therapy, physical therapy, rheumatology, and social work.
Consensus among the Voting Panel members required ≥70% agreement on both direction (for or against) and strength (strong or conditional) of each recommendation, as per ACR practice. According to GRADE, a recommendation is categorized as strong if the panel is very confident that the benefits of an intervention clearly outweigh the harms (or vice versa); a conditional recommendation denotes uncertainty regarding the balance of benefits and harms, such as when the evidence quality is low or very low, or when the decision is particularly sensitive to individual patient preferences, or when costs are expected to affect the decision. Thus, conditional recommendations refer to decisions in which incorporation of patient preferences and values is an essential element of shared decision making.
Guiding Principles
Eight guiding principles (Table 2) were established by the Core Leadership Team to aid in the preparation of this guideline. These guiding principles specify that integrative interventions considered in this guideline should complement pharmacologic treatments, an interprofessional approach for the management of RA should be used, and shared decision making is needed when caring for people with RA.
Table 2.
Integrative Rheumatoid Arthritis Guideline Guiding Principles |
---|
Rheumatoid arthritis is a chronic, systemic, inflammatory condition that requires early diagnosis, evaluation, and management to achieve optimal outcomes. Persons with chronic diseases, like rheumatoid arthritis, seek many available therapies to maintain physical function, reduce pain, and improve their quality of life. |
Rheumatoid arthritis should be treated with disease-modifying anti-rheumatic drugs and follow a treat-to-target management strategy, as detailed in the 2021 American College of Rheumatology (ACR) Rheumatoid Arthritis Pharmacologic Treatment Guidelines (1). |
Treatment decisions should follow a shared decision-making process. Persons with rheumatoid arthritis present with a variety of manifestations and experiences. |
Optimum rheumatoid arthritis treatment outcomes are achieved through interprofessional teams providing expert patient-centered care. |
Recommendations assume no contraindications to listed management strategies. |
Recommendations pertain to rheumatoid arthritis management. Recommendations do not pertain to clinical situations when patients have alternative indications for listed treatments. Other general health benefits may exist for listed treatments. |
Surgical interventions are not included in this guideline because there are other guideline efforts that address large joint replacement, and small joint surgeries are not frequently a part of the current management of rheumatoid arthritis. |
Disease activity and disease activity levels refer to those calculated using an ACR-endorsed RA disease activity measure (2). |
Fraenkel L, Bathon JM, England BR, St. Clair EW, Arayssi T, Carandang K, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res 2021;73:924–939.
England BR, Tiong BK, Bergman MJ, Curtis JR, Kazi S, Mikuls TR, et al. 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures. Arthritis Care. 2019;71:1540–1555.
RESULTS/RECOMMENDATIONS
Twenty-eight recommendations were made based on a set of 28 PICO questions. The systematic literature review initially identified 8,994 manuscripts. After screening, 275 manuscripts were mapped to ≥1 PICO question (see flow diagram in Supplementary Appendix 5). The literature review did not identify any evidence fulfilling eligibility criteria for 29% (8/28) of the PICO questions.
Exercise recommendations (Table 3)
Table 3.
Recommendation | Certainty of Evidence | Based on the Evidence Report of the Following PICO(s) | Page no(s) of Evidence Table(s) in Suppl. App. 3* |
---|---|---|---|
Consistent engagement in exercise is strongly recommended over no exercise. | Moderate | 4–7 | 205–354 |
Consistent engagement in aerobic exercise is conditionally recommended over no exercise. | Very low to Low | 4 | 205–252 |
Consistent engagement in aquatic exercise is conditionally recommended over no exercise. | Low | 5 | 253–270 |
Consistent engagement in resistance exercise is conditionally recommended over no exercise. | Very low | 6 | 271–327 |
Consistent engagement in mind-body exercise is conditionally recommended over no exercise. | Very low to low | 7 | 328–354 |
Insert link to Supplementary Appendix 3 on journal website – TBD
Intervention definitions and examples are provided in Table 1.
Consistent engagement in exercise is strongly recommended over no exercise.
This recommendation is based on moderate certainty evidence suggesting improved physical function and pain. Aerobic, resistance, aquatic, and mind-body exercise were considered together in the evidence supporting this recommendation. The exercise type, frequency, intensity, and duration were not formally defined, though the Voting and Patient Panels emphasized “moving regularly”. The specific elements of an exercise intervention should be tailored to each patient at the given time in their disease trajectory, considering their capabilities, access, and other health conditions. National physical activity guidelines can aid such instruction (8).
Consistent engagement in aerobic exercise is conditionally recommended over no exercise.
This recommendation is based on very low to low certainty evidence suggesting improved physical function but moderate certainty evidence of no difference in pain. The recommendation is conditional because of the certainty of evidence and recognizing that patient preferences may vary due to RA disease activity level, the presence of joint damage or deformities, comorbidities, and the cost, access, or burden of engaging in consistent aerobic exercise.
Consistent engagement in aquatic exercise is conditionally recommended over no exercise.
This recommendation is based on low certainty evidence of improvement in physical function but no difference in pain. The recommendation is conditional because of the certainty of evidence, variability in patient preferences related to comfort in water, cost, access, and burden.
Consistent engagement in resistance exercise is conditionally recommended over no exercise.
This recommendation is based on very low to low certainty evidence of improvement in physical function (inferred from performance measures) and pain. The recommendation is conditional because of the certainty of evidence, variability in patient preferences related to joint damage or deformities that may limit participation, access, cost, and burden. The Voting Panel and patient panel emphasized the importance of appropriate prescription and supervision of resistance exercise by physical therapists or other qualified exercise professionals to prevent harm.
Consistent engagement in mind-body exercise (yoga, Tai Chi, qigong) is conditionally recommended over no exercise.
This recommendation is based on very low to low certainty evidence of improvement in physical function but no difference in pain. The recommendation is conditional because of the certainty of evidence, variability in patient preferences, cost, access, and burden.
Rehabilitation recommendations (Table 4)
Table 4.
Recommendation | Certainty of Evidence | Based on the Evidence Report of the Following PICO(s) | Page no(s) of Evidence Table(s) in Suppl. App. 3* |
---|---|---|---|
Participation in comprehensive occupational therapy is conditionally recommended over no comprehensive occupational therapy. | Very low | 17 | 419–437 |
Participation in comprehensive physical therapy is conditionally recommended over no comprehensive physical therapy. | Very low | 18 | 438–453 |
For patients with hand involvement, performing hand therapy exercises is conditionally recommended over no hand therapy exercises. | Low | 8 | 355–378 |
For patients with hand and/or wrist involvement and/or deformity, use of splinting, orthoses, and/or compression is conditionally recommended over no splinting, orthoses, and/or compression. | Very low | 9 | 379–386 |
For patients with foot and/or ankle involvement, use of bracing, orthoses, and/or taping is conditionally recommended over no bracing, orthoses, and/or compression. | Very low | 10 | 387–408 |
For patients with knee involvement, use of bracing and/or orthoses is conditionally recommended over no bracing and/or orthoses. | No studies met eligibility criteria | 11 | 409 |
Use of joint protection techniques is conditionally recommended over no joint protection techniques. | Low | 12 | 410–413 |
Use of activity pacing, energy conservation, activity modification, and/or fatigue management is conditionally recommended over no activity pacing, energy conservation, activity modification, and/or fatigue management. | No studies met eligibility criteria | 13 | 415 |
Use of assistive devices is conditionally recommended over no assistive devices. | No studies met eligibility criteria | 14 | 416 |
Use of adaptive equipment is conditionally recommended over no adaptive equipment. | No studies met eligibility criteria | 15 | 417 |
Use of environmental adaptations is conditionally recommended over no environmental adaptations. | No studies met eligibility criteria | 16 | 418 |
For patients who are currently employed or desire to become employed, use of vocational rehabilitation is conditionally recommended over no work interventions. | No studies met eligibility criteria | 21 | 510 |
For patients who are currently employed or desire to become employed, work site evaluations and/or modifications are conditionally recommended over no work site evaluations and/or modifications. | Low | 22 | 511–517 |
Insert link to Supplementary Appendix 3 on journal website – TBD
Intervention definitions and examples are provided in Table 1.
Participation in comprehensive occupational therapy (OT) is conditionally recommended over no comprehensive OT.
Participation in comprehensive physical therapy (PT) is conditionally recommended over no comprehensive PT.
These recommendations are conditional based on very low certainty evidence of improvement in pain and physical function, expected variability in patient preferences, burden, access, and cost. In these recommendations, comprehensive refers to the numerous different approaches and interventions that occupational therapists and physical therapists utilize in the assessment and management of people with RA. The comprehensive nature of these interventions also highlights the importance of expertise and experience in tailoring these interventions to the management of RA through a shared decision-making approach. This recommendation applies throughout the RA disease course. Clinicians should discuss the opportunity to refer to OT and/or PT early in the RA disease course with the recognition that OT and/or PT interventions can be tailored to unique patient needs throughout the patient’s experience with RA. Access to OT and PT services (e.g., availability, insurance coverage) may be a barrier to care. Interventions in the subsequent recommendation statements are often included in comprehensive OT and/or PT services.
For patients with hand involvement, performing hand therapy exercises is conditionally recommended over no hand therapy exercises.
This recommendation is conditional based on low certainty evidence of pain reduction and improvement in physical function. Evaluation of the unique needs of the person with RA with hand involvement is best performed by an experienced hand therapist (e.g., a certified hand therapist (CHT) who is typically an occupational or physical therapist with additional training) who can guide the specific design and intensity of the intervention.
For patients with hand and/or wrist involvement and/or deformity, use of splinting, orthoses, and/or compression is conditionally recommended over no splinting, orthoses, and/or compression.
For patients with foot and/or ankle involvement, use of bracing, orthoses, and/or taping is conditionally recommended over no bracing, orthoses, and/or compression.
For patients with knee involvement, use of bracing and/or orthoses is conditionally recommended over no bracing and/or orthoses.
These recommendations are conditional based on very low (no studies met eligibility criteria for this PICO) certainty evidence of improvement in pain and physical function at the respective anatomic sites. Although the Patient Panel discussed the discomfort and burden accompanying the periodic and regular use of these interventions, the Patient Panel and Voting Panel also recognized their potential to reduce pain and improve physical function. In addition, although these interventions are available without a prescription, the Voting Panel recommends their prescription and use under the guidance of an experienced occupational therapist or physical therapist to ensure appropriate item selection and fit.
Use of joint protection techniques is conditionally recommended over no joint protection techniques.
This recommendation is conditional based on low certainty evidence of improvement in pain and function. Experienced healthcare professional guidance in joint protection techniques at various stages of a patient’s experience with RA is vital for this intervention to aid the patient in maintaining physical function. The Voting Panel also stressed the importance of proper patient education in joint protection techniques by occupational or physical therapists.
Use of activity pacing, energy conservation, activity modification, and/or fatigue management is conditionally recommended over no activity pacing, energy conservation, activity modification, and/or fatigue management.
There was no evidence found for this PICO question. However, these interventions are generally safe and may help preserve physical function and manage fatigue. Proper instruction in these approaches by occupational or physical therapists as well as periodic reminders to employ them were suggested by the Patient Panel and Voting Panel.
Use of assistive devices is conditionally recommended over no assistive devices.
Use of adaptive equipment is conditionally recommended over no adaptive equipment.
Use of environmental adaptations is conditionally recommended over no environmental adaptations.
In the absence of evidence addressing these PICO questions, a conditional recommendation was made in favor of using assistive devices/equipment because of the potential for meaningfully improving function and quality of life and the lack of known harms. The timing of the use of interventions, guidance on intervention selection, and education on how to use these interventions should be considered. Involving an occupational or physical therapist can aid these processes and ensure patient safety. The Voting Panel recognized cost and burden as barriers to the use of these interventions.
For patients who are currently employed or want to become employed, use of vocational rehabilitation (training programs to support employment) is conditionally recommended over no vocational rehabilitation.
For patients who are currently employed or want to become employed, work site evaluations and/or modifications are conditionally recommended over no work site evaluations and/or modifications
These recommendations were conditional based on the absence of evidence for vocational rehabilitation and low certainty evidence for work site evaluations and modifications. The Voting Panel recognized the following considerations in implementing worksite evaluations and modifications: 1) the employee/employer relationship regarding health-specific variables and confidentiality, 2) comfort with disclosure of RA to the employer, 3) the requirements of the Americans with Disabilities Act and the Family and Medical Leave Act, 4) the heterogeneity of employer resources and employee job responsibilities, and 5) the variable availability of experienced work and ergonomics specialists.
Diet recommendations (Table 5)
Table 5.
Recommendation | Certainty of Evidence | Based on the Evidence Report of the Following PICO(s) | Page no(s) of Evidence Table(s) in Suppl. App. 3* |
---|---|---|---|
Adherence to a Mediterranean-style diet is conditionally recommended over no formally defined diet. | Low to moderate | 1 | 8–86 |
Adherence to a formally defined diet, other than Mediterranean-style, is conditionally recommended against. | Very low to moderate | 1 | 8–86 |
Following established dietary recommendations without dietary supplements is conditionally recommended over adding dietary supplements. | Very low to moderate | 2 | 87–201 |
Insert link to Supplementary Appendix 3 on journal website – TBD
Intervention definitions and examples are provided in Table 1.
Adherence to a Mediterranean-style diet is conditionally recommended over no formally defined diet.
The Mediterranean-style diet pattern emphasizes the intake of vegetables, fruits, whole grains, nuts, seeds, and olive oil; moderate amounts of low-fat dairy and fish; and limits added sugars, sodium, highly processed foods, refined carbohydrates, and saturated fats. This recommendation is based on low to moderate certainty of evidence of improvement in pain and no difference in physical function or disease activity. The recommendation is conditional because of the evidence certainty, patient preferences, costs, access, and burden. The Voting Panel recognized the potential benefits of a Mediterranean-style diet for long-term health outcomes (e.g., longevity and cardiovascular disease) that are affected by RA disease activity and the evidence from studies in the general population (9, 10). The expert role of a registered dietician as a member of the interprofessional team is recognized.
Adherence to a formally defined diet, other than a Mediterranean-style diet, is conditionally recommended against.
This recommendation is based on very low to moderate certainty evidence demonstrating no consistent, clinically meaningful benefit on physical function, pain, or disease activity specific to RA for formally defined diets other than a Mediterranean-style diet (listed in Table 1). In addition to the certainty of evidence, this recommendation is conditional because of the burden and costs that accompany adhering to a formally defined diet and patient preferences are expected to differ.
Following established dietary recommendations without dietary supplements is conditionally recommended over adding dietary supplements.
This recommendation for RA management pertains to all dietary supplements considered (listed in Table 1) and is based on very low to moderate certainty evidence demonstrating no consistent, clinically meaningful benefit on physical function, pain, or disease activity specific to RA. The recommendation is conditional because of the certainty of evidence, expected variation in patient preferences, adequacy of nutrient intake through diet, lack of regulation (e.g., U.S. Food and Drug Administration), possibility of harm (e.g., interactions with medications, side effects), and costs. The Voting Panel supported a “food first” approach but recognized the role dietary supplements may serve for bone (e.g., Vitamin D) and cardiovascular (e.g., fish oil) health, which are particularly important in people with RA (11). In this recommendation, established dietary recommendations refer to those produced by the U.S. Department of Agriculture and U.S. Department of Health & Human Services (12) and the American Heart Association (13). Recommendations on folic acid supplementation in the setting of treatment with methotrexate are included in the pharmacologic treatment guidelines (1).
Body weight and weight loss
Given the broad spectrum of weight loss interventions, including lifestyle modification, commercial weight loss programs, pharmacologic therapies, and surgical interventions, the Voting Panel did not vote on recommendations regarding specific weight loss interventions in overweight or obese people with RA specifically for RA management. However, the Voting Panel was unanimous in its support of clinicians engaging in discussion about maintaining a healthy body weight for people with RA to optimize long-term RA and general health outcomes. In RA, obesity is associated with higher disease activity, impairments in physical function, and poorer treatment response, in addition to poor long-term health outcomes (14). General population recommendations on body weight classification and weight loss strategies, for those who are overweight or obese, can serve as a guide for these discussions (15, 16).
Additional integrative intervention recommendations (Table 6)
Table 6.
Recommendation | Certainty of Evidence | Based on the Evidence Report of the Following PICO(s) | Page no(s) of Evidence Table(s) in Suppl. App. 3* |
---|---|---|---|
Use of a standardized self-management program is conditionally recommended over no standardized self-management program. | Low | 19 | 454–466 |
Use of cognitive behavioral therapy and/or mind-body approaches is conditionally recommended over no cognitive behavioral therapy and/or mind-body approaches. | Very low to low | 20 | 467–510 |
Use of acupuncture is conditionally recommended over no acupuncture. | Low | 23 | 518–538 |
Use of massage therapy is conditionally recommended over no massage therapy. | Very low | 24 | 539–543 |
Use of thermal modalities is conditionally recommended over no thermal modalities. | Very low | 25 | 544–563 |
Using electrotherapy is conditionally recommended against. | Low | 26 | 564–572 |
Using chiropractic therapy is conditionally recommended against. | No studies met eligibility criteria | 27 | 573 |
Insert link to Supplementary Appendix 3 on journal website – TBD
Intervention definitions and examples are provided in Table 1.
Use of a standardized self-management program is conditionally recommended over no standardized self-management program.
This recommendation is conditional based on low certainty evidence of improvement in physical function and pain. The Patient Panel described how these programs can be “life changing” and can provide motivation related to several factors that contribute to quality of life including mental wellness and psychological adaptation to disease experience. The availability of and access to these programs as well as their costs were noted as potential barriers.
Use of cognitive behavioral therapy and/or mind-body approaches is conditionally recommended over no cognitive behavioral therapy and/or mind-body approaches
This conditional recommendation is based on very low to low certainty evidence of no consistent improvement in pain and physical function (critical outcomes), but low to moderate certainty evidence of improvement in depression, anxiety, fatigue, and sleep (important outcomes). Although these interventions are beneficial for chronic disease management, access to experienced healthcare professionals, cost, and the burden of using these interventions were recognized barriers.
Use of acupuncture is conditionally recommended over no acupuncture.
This recommendation for using acupuncture is conditional based on low certainty evidence of inconsistent improvements in pain and function. The Patient Panel generally found acupuncture to be of lower value than other considered interventions for RA management based on their disease experiences. For people with RA, the burden, cost, access, and invasiveness may impact the choice to use this intervention.
Use of massage therapy is conditionally recommended over no massage therapy.
This recommendation for using massage therapy is conditional based on very low certainty evidence of improvement of pain. Massage therapy intensity and technique may affect a patient’s experience; therefore, it is best delivered by a provider (e.g., massage therapist, physical therapist) with knowledge and experience of treating people with RA. Burden, cost, access, and short-term duration of benefit should be considered.
Use of thermal modalities is conditionally recommended over no thermal modalities.
This recommendation for using thermal modalities, such as cryotherapy, heat, and therapeutic ultrasound, is conditional based on very low certainty evidence of improvement for pain and physical function. People with RA receive varying levels of benefit from thermal modalities, and patient preferences are expected to vary regarding the choice of a thermal modality. Patients can control and administer many of these modalities at home though others may benefit from guidance from an occupational or physical therapist.
Using electrotherapy is conditionally recommended against.
This recommendation for “not” using electrotherapy modalities, such as transcutaneous electrical nerve stimulation (TENS) and neuro-muscular electrical nerve stimulation, for RA management is conditional based on low certainty evidence of no improvement of pain and physical function specific to RA. While some people with RA may receive benefit from these interventions (e.g., in the setting of comprehensive PT or OT), the Voting Panel recommended against electrotherapy because the evidence was not felt to outweigh the burden and costs.
No recommendation was made by the Voting Panel on the use of vagus nerve stimulation because this invasive procedure is not currently approved by the FDA for RA.
Using chiropractic therapy is conditionally recommended against.
In the absence of evidence, this recommendation for “not” using chiropractic therapy (i.e., chiropractic spinal adjustment) directly for the management of RA is conditional because of the potential cervical spine complications that can occur in people with RA (17), Voting and Patient Panels’ perceived lack of benefit specific to RA, burden, and costs.
Tobacco cessation
Due to existing clinical quality measures for tobacco use screening and cessation (18) and the absence of studies on tobacco cessation in RA that met eligibility criteria, the Voting Panel did not make further recommendations on individual tobacco cessation interventions for the specific management of RA beyond the clinical quality measures. The Voting Panel recognized the well-established harms of tobacco including detrimental effects on RA that include higher disease severity, poorer treatment response, and increased risk of poor long-term disease outcomes (19). Because of the trust that is frequently developed between people with RA and their clinicians and the low success rate of individual tobacco cessation counseling efforts (20), there was unanimous agreement that clinicians caring for people with RA serve an integral role in counseling on tobacco cessation (21).
DISCUSSION
This is the first guideline produced by the ACR on the use of exercise, rehabilitation, diet, and additional integrative interventions in conjunction with DMARDs for the management of RA. This guideline highlights the importance of an interprofessional healthcare team in providing optimal care to people with RA. The recommended interventions do not replace DMARD treatments in accordance with existing ACR pharmacologic treatment guidelines (1) but are intended to be integrated into the comprehensive management of people with RA. Additionally, the recommended interventions were considered for their efficacy for the management of RA outcomes specifically, rather than other general health benefits or alternative medical indications. The guideline is meant to increase patient and clinician awareness of these interventions, provide evidence to inform shared decision making, improve access to the recommended interventions, and inspire much-needed future research into the integrative management of RA to generate higher-certainty evidence for the management of RA.
The one strong recommendation in this guideline was for consistent engagement in exercise. Most people with RA are expected to benefit from engaging in exercise. However, the specific exercise modality should be determined by patient preference and values, considering the potential burden on and capacity of each patient (22). Recommendations for exercise include multiple types (aerobic, aquatic, resistance, mind-body), which is consistent with physical activity guidelines produced by the U.S. Department of Health and Human Services (8). The frequency, intensity, and duration of exercise were not specified in the recommendation statement, recognizing that these specifics will need to be tailored to each person. The U.S. recommendations on exercise and physical activity can serve as a guide to clinicians counseling patients (8). Benefits of exercise and being physically active extend beyond management of RA symptoms, with evidence from the general population suggesting improved longevity, a lower risk of developing chronic diseases that are overrepresented in RA (e.g., cardiovascular disease), and improved mental health (8). Because symptoms and consequences of RA may impact participation (23), more personalized exercise prescription and monitoring may be needed with the assistance of physical therapists and/or clinical exercise physiologists.
Several rehabilitation interventions as well as comprehensive OT and PT were recommended for their benefits on pain, physical function, preserving independence, remaining in work, and safety, although the certainty of evidence was low or very low. Consistently, the Patient Panel emphasized the importance of receiving these interventions from occupational and/or physical therapists to ensure proper use, exemplifying the unique and substantial contributions these professions provide to the interprofessional RA care team. Patient panel members also reported wishing they had been referred to occupational and physical therapists earlier in the disease course. Clinicians should consider discussing rehabilitation interventions and involving occupational and physical therapists early in the disease course. Early referral to these services can provide education to people with RA on ways to independently use these interventions (e.g., exercise, joint protection, energy conservation, assistive and adaptive devices) to self-manage their disease. Ensuring a sufficient workforce of occupational and physical therapists well-versed in the management of RA and access to this care are high priorities.
Dietary patterns and quality have been associated with RA risk and severity in many, though not all, epidemiologic studies (24). Of several diets evaluated in this guideline (e.g., vegan, anti-inflammatory, elimination), only a Mediterranean-style diet had sufficient evidence to be recommended, given the burden and costs that accompany adhering to a formally defined diet. Dietary supplements were heavily debated by the Voting Panel. Ultimately, there was not sufficient evidence to recommend use of dietary supplements for RA management. The Voting Panel supported a “food first” approach, which emphasizes using high-quality foods to obtain necessary nutrients. Although no recommendation was made on weight loss interventions, the Voting Panel was unanimous in their support for maintaining a healthy body weight. Rheumatology clinicians should consider involving registered dieticians as part of the interprofessional care team to assist people with RA who desire to modify their diet as part of their RA management plan.
Additional integrative interventions that were conditionally recommended included standardized self-management programs, CBT and mind body approaches, acupuncture, massage therapy, and thermal modalities. Although the evidence supporting these interventions was of very low to low certainty, these interventions possess few harms and a modest burden for many people. The Patient Panel favored standardized self-management, CBT, mind body approaches, and thermal modalities because they felt empowered by the interventions, were better able to cope with the chronic disease aspects of RA, and/or it provided them a management option they could control independently, often in their own home.
People with RA who are currently using tobacco should be supported in their tobacco cessation journey. The limited efficacy of counseling on tobacco cessation (20) illustrates why it is critical for all members of the interprofessional care team to engage in this practice, which is an existing clinical quality measure (25). There was not sufficient evidence to establish any formal recommendations for RA beyond the existing quality measures.
A broad range of interventions was considered in this guideline. It is highly unlikely that one clinician will possess the necessary expertise in all these areas, which illustrates the importance of assembling an interprofessional healthcare team to best support people with RA. The Patient Panel emphasized that rheumatology clinicians (e.g., physicians, physician assistants, nurse practitioners) are most often the first contact for therapeutic decisions. Thus, it was important to patients that their rheumatology clinician(s) be knowledgeable about these integrative therapies and help guide patients to other members of the interprofessional care team with the relevant expertise. These discussions should take place early in the disease course and provide patients with options of therapies/interventions and the clinicians who could support them through their disease experience. In addition to the rheumatology clinician, potential members of the interprofessional team include physical and occupational therapists, dieticians, clinical exercise physiologists, psychologists, massage therapists, acupuncturists, and others. The timing in the disease course when a patient might need to involve each care team member will depend on their specific situation and preferences.
RA is a chronic disease that imposes considerable costs to affected persons and society (26, 27). The recommended interventions in this guideline are variably covered by health insurance, and many of the costs become the responsibility of the person with RA. We encourage health policymakers to support the coverage of these interventions to support an integrative and comprehensive approach to the management of RA. In addition to cost concerns, the availability of and access to these interventions was a concern of both the Patient Panel and Voting Panel, particularly for underserved populations. Improving access to and ensuring high-quality delivery of these interventions across diverse settings are important endeavors to immediately support. The Voting Panel acknowledged that patients and/or clinicians may have implicit and/or explicit biases regarding the considered interventions that may make them reluctant to recommend or use these interventions (28). While the evidence-based approach used in this guideline can help overcome such biases, clinicians should consider whether such biases may exist and work to reduce them.
The majority of recommendations were conditional because of low certainty evidence for each intervention. Several factors contributed to the low-certainty evidence, including the limited number of studies evaluating relevant interventions, lack of blinding and study attrition, small sample sizes resulting in imprecision, and heterogeneity of study designs (e.g., various interventions, comparators, and outcomes) that prevented pooling results through a formal meta-analysis. Many of these problems resulted from inherent difficulties in conducting clinical trials evaluating the considered interventions. These conditional recommendations indicate that clinicians should engage in shared decision making with patients when deciding whether to use these interventions. The low or very low certainty evidence supporting most recommendations calls for prioritizing research into these interventions and prompted the Core Team and Voting Panel to propose a research agenda (Table 7). Key research agenda items include determining the efficacy, safety, optimal timing, mode of delivery, and personalization of these interventions.
Table 7.
Evaluate the efficacy and safety of integrative therapies for the management of RA. Initial evidence is needed in the areas of activity pacing, energy conservation, activity modification, fatigue management, and vocational rehabilitation. Additional strong evidence from larger, well-designed studies is needed in all other areas. |
Determine the appropriate timing of different integrative interventions in the RA disease course. |
Examine the delivery, education, and implementation of integrative interventions. For example, evaluating various methods of instruction and training of joint protection and activity pacing interventions. |
Establish the cost-effectiveness of different integrative interventions and develop approaches for cost-effective delivery. |
Identify barriers to the adoption and implementation of integrative therapies. These may include variability in access, costs, and implicit and/or explicit biases. |
Describe the assembly of, communication between, and role delineation among the interprofessional care team delivering pharmacologic and integrative interventions. |
Improve access to experienced healthcare professionals who provide integrative interventions. |
Determine efficacy and safety of integrative interventions based on RA disease manifestations and pharmacologic therapies, e.g., modifying exercise interventions based on disease activity level or diet based on disease-modifying anti-rheumatic drugs utilized. |
Tailor interventions (and their delivery) studied in the general population to persons with RA, e.g., tobacco cessation programs, exercise programs, and weight loss. |
Define efficacy and safety of therapies not included in this guideline such as cannabidiol, vaping, and occupational exposures and protections as well as emerging therapies such as vagal nerve stimulation. |
Evaluate dietary supplements (especially Vitamin D and Omega-3 fatty acids such as “fish oil”) in the context of dietary intake. The assessment and implementation of diets should focus on being inclusive of different cultures. |
Develop vocational rehabilitation programs and work site modifications that improve the ability of persons with RA to work without negative stigma in the workplace. |
Establish the efficacy and safety of integrative therapies on extra-articular manifestations and long-term RA-related outcomes. In addition to disease activity, physical function, pain, and quality of life outcomes considered in this guideline, other outcomes that should be considered are longevity, cardiovascular disease, lung disease, cancer, osteoporosis, and infection. |
Develop research methodology to study integrative therapies, e.g., defining an adequate control intervention. Publication of research standards for integrative therapies relevant to RA to guide research efforts. |
Establish dedicated funding from organizations to study integrative RA therapies and their implementation. |
There are additional limitations to the development of these guidelines beyond the generally low certainty evidence. Studies that were conducted prior to more recent treatment eras (characterized by early diagnosis and a treat-to-target approach) were included in the evidence report and may be less generalizable than more recently completed studies. In addition, although broad expertise was recruited and an extensive list of interventions considered in this guideline, we could not ensure expertise in every area of integrative RA management or consider all possible integrative interventions. Additional integrative interventions can be considered for inclusion in future guidelines. For example, members of the Patient Panel inquired about cannabinoids given the rising prevalence of their use in rheumatic diseases (29, 30). Cannabinoids were not included in this guideline, and emerging evidence for cannabidiol, a pharmacologic therapy that is not FDA-approved for RA, is being synthesized in a living systematic review through a joint U.S. Department of Veterans Affairs and Center for Evidence-Based Policy at Oregon Health & Sciences University (31). In addition, different modes of delivering interventions (e.g., telehealth vs. in-person) were not assessed, as this was beyond the scope of this project.
In summary, we have provided initial recommendations on the management of RA with exercise, rehabilitation, diet, and additional integrative interventions. These recommendations complement existing pharmacologic treatment guidelines that instruct on the use of DMARDs and, together, can guide a shared decision-making approach between patients and clinicians. Interprofessional treatment teams are crucial to implementing these recommendations. The generally low-quality evidence highlights the need for well-designed studies in the area of integrative management of RA. Policy efforts are needed to ensure access to recommended interventions for people with RA from diverse backgrounds and settings. Together, the integrative and pharmacologic guidelines support the comprehensive management of RA in pursuit of optimal outcomes for people living with RA.
Supplementary Material
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to the recommendations within this guideline to be voluntary, with the ultimate determination regarding their application to be made by the clinician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed and endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. ACR recommendations are not intended to dictate payment or insurance decisions, and drug formularies or other third-party analyses that cite ACR guidelines should state this. These recommendations cannot adequately convey all uncertainties and nuances of patient care.
The American College of Rheumatology is an independent, professional medical, and scientific society that does not guarantee, warrant, or endorse any commercial product or service.
SIGNIFICANCE.
This is the first American College of Rheumatology clinical practice guideline addressing integrative interventions for the management of rheumatoid arthritis (RA).
Use of integrative interventions for the management of RA should occur in concert with disease-modifying anti-rheumatic drugs according to ACR guidelines for pharmacologic treatment of RA (1).
This guideline highlights the vital role expert members of interprofessional healthcare teams serve in providing optimal care to people with RA.
People with RA desire awareness of different management options early in their disease course and seek counsel from their interprofessional healthcare team to decide when to employ the use of these management options.
ACKNOWLEDGEMENTS
We thank the patients who (along with authors Deb Constien, Eileen Davidson, and Lawrence “Rick” Phillips) participated in the Patient Panel meeting: Grace M. Becker, Denise Cedar, Judith Flanagan, Carolyn R. Mason, Eileen Julie O’Rourke, Catherine Simons, Sharon A. Sharp, and Sumayya Spencer. We thank the ACR staff, including Regina Parker for assistance in coordinating the administrative aspects of the project and Cindy Force for assistance with manuscript preparation. We thank Janet Waters for her assistance in developing the literature search strategy, as well as performing the initial literature search and update searches. We thank Theresa Wampler Muskardin and Karen Smarr for their thoughtful review and feedback during the project.
Grant Support:
This guideline project was supported by the American College of Rheumatology.
Footnotes
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Veterans Affairs.
Financial Conflict: Forms submitted as required.
IRB Approval: Approval from Human Studies Committees was not required.
REFERENCES
- 1.Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis care & research. 2021;73(7):924–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis and rheumatism. 2008;59(6):762–84. [DOI] [PubMed] [Google Scholar]
- 3.Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis care & research. 2012;64(5):625–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Singh JA, Saag KG, Bridges SL Jr., Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, NJ). 2016;68(1):1–26. [DOI] [PubMed] [Google Scholar]
- 5.Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. Journal of clinical epidemiology. 2013;66(7):726–35. [DOI] [PubMed] [Google Scholar]
- 6.Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2010;182(18):E839–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Physical Activity Guidelines for Americans 2nd edition: U.S. Department of Health and Human Services; 2018. [Available from: https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf.
- 9.Ge L, Sadeghirad B, Ball GDC, da Costa BR, Hitchcock CL, Svendrovski A, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ (Clinical research ed). 2020;369:m696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. The Cochrane database of systematic reviews. 2019;3(3):Cd009825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis care & research. 2017;69(8):1095–110. [DOI] [PubMed] [Google Scholar]
- 12.U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020–2025. 9th Edition. 2020. Available at https://www.DietaryGuidelines.gov [Google Scholar]
- 13.Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144(23):e472–e87. [DOI] [PubMed] [Google Scholar]
- 14.Poudel D, George MD, Baker JF. The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis. Current rheumatology reports. 2020;22(9):56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement. Jama. 2018;320(11):1163–71. [DOI] [PubMed] [Google Scholar]
- 16.Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gillick JL, Wainwright J, Das K. Rheumatoid Arthritis and the Cervical Spine: A Review on the Role of Surgery. International journal of rheumatology. 2015;2015:252456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Explore Measures & Activities [Available from: https://qpp.cms.gov/mips/explore-measures.
- 19.Vittecoq O, Richard L, Banse C, Lequerré T. The impact of smoking on rheumatoid arthritis outcomes. Joint bone spine. 2018;85(2):135–8. [DOI] [PubMed] [Google Scholar]
- 20.Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. The Cochrane database of systematic reviews. 2013;2013(5):Cd000165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Vreede AP, Johnson HM, Piper M, Panyard DJ, Wong JC, Bartels CM. Rheumatologists Modestly More Likely to Counsel Smokers in Visits Without Rheumatoid Arthritis Control: An Observational Study. JCR: Journal of Clinical Rheumatology. 2017;23(5):273–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Spencer-Bonilla G, Quiñones AR, Montori VM. Assessing the Burden of Treatment. Journal of general internal medicine. 2017;32(10):1141–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Sokka T, Häkkinen A, Kautiainen H, Maillefert JF, Toloza S, Mørk Hansen T, et al. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis and rheumatism. 2008;59(1):42–50. [DOI] [PubMed] [Google Scholar]
- 24.Philippou E, Nikiphorou E. Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis. Autoimmunity reviews. 2018;17(11):1074–7. [DOI] [PubMed] [Google Scholar]
- 25.Bartels CM, Johnson L, Ramly E, Panyard DJ, Gilmore-Bykovskyi A, Johnson HM, et al. Impact of a Rheumatology Clinic Protocol on Tobacco Cessation Quit Line Referrals. Arthritis care & research. 2022;74(9):1421–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hresko A, Lin TC, Solomon DH. Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis. Arthritis care & research. 2018;70(10):1431–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hsieh PH, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Annals of the rheumatic diseases. 2020;79(6):771–7. [DOI] [PubMed] [Google Scholar]
- 28.Green JA, Hohmann C, Lister K, Albertyn R, Bradshaw R, Johnson C. Implicit and explicit attitudes towards conventional and complementary and alternative medicine treatments: Introduction of an Implicit Association Test. Journal of health psychology. 2016;21(6):927–33. [DOI] [PubMed] [Google Scholar]
- 29.Katz-Talmor D, Katz I, Porat-Katz BS, Shoenfeld Y. Cannabinoids for the treatment of rheumatic diseases - where do we stand? Nature reviews Rheumatology. 2018;14(8):488–98. [DOI] [PubMed] [Google Scholar]
- 30.Wipfler K, Simon TA, Katz P, Wolfe F, Michaud K. Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study. Arthritis care & research. 2021. [DOI] [PubMed] [Google Scholar]
- 31.Evidence-based research about cannabis: STEM: Systematically Testing the Evidence on Marijuana; [Available from: https://www.cannabisevidence.org/.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.